Sanofi Pays $2.4M To Kill Cancer Drug Sales Class Action
Sanofi-Aventis US LLC has agreed to pay $2.4 million to employees who alleged the pharmaceutical giant shorted them commission payments from sales of the cancer drug Zaltrap, according to a preliminary...To view the full article, register now.
Already a subscriber? Click here to view full article